PL2544705T3 - Interferon beta do zastosowania w leczeniu schorzenia dolnych dróg oddechowych powodowanego przez grypę - Google Patents

Interferon beta do zastosowania w leczeniu schorzenia dolnych dróg oddechowych powodowanego przez grypę

Info

Publication number: PL2544705T3
Authority: PL; Poland
Prior art keywords: influenza; treatment; respiratory tract; interferon beta; lower respiratory
Prior art date: 2010-03-12

Application number

PL11730046T

Other languages

English (en)

Inventor

Victoria Jane Tear

James Jonathan Welch Roberts

Phillip David Monk

Original Assignee

Synairgen Research Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-03-12

Filing date

2011-03-10

Publication date

2017-02-28

2010-03-12 Priority claimed from GBGB1004144.0A external-priority patent/GB201004144D0/en

2010-05-17 Priority claimed from GBGB1008114.9A external-priority patent/GB201008114D0/en

2011-03-10 Application filed by Synairgen Research Limited filed Critical Synairgen Research Limited

2017-02-28 Publication of PL2544705T3 publication Critical patent/PL2544705T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Otolaryngology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL11730046T 2010-03-12 2011-03-10 Interferon beta do zastosowania w leczeniu schorzenia dolnych dróg oddechowych powodowanego przez grypę PL2544705T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB1004144.0A GB201004144D0 (en)	2010-03-12	2010-03-12	Therapy for influenza like illness
GBGB1008114.9A GB201008114D0 (en)	2010-05-17	2010-05-17	Therapy for influenza like illness

Publications (1)

Publication Number	Publication Date
PL2544705T3 true PL2544705T3 (pl)	2017-02-28

Family

ID=44563925

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL11730046T PL2544705T3 (pl)	2010-03-12	2011-03-10	Interferon beta do zastosowania w leczeniu schorzenia dolnych dróg oddechowych powodowanego przez grypę

Country Status (17)

Country	Link
US (1)	US9421243B2 (pl)
EP (1)	EP2544705B1 (pl)
JP (1)	JP5926200B2 (pl)
CN (2)	CN102883741A (pl)
CA (1)	CA2792727C (pl)
CY (1)	CY1117985T1 (pl)
DK (1)	DK2544705T3 (pl)
ES (1)	ES2592528T3 (pl)
HR (1)	HRP20161158T1 (pl)
HU (1)	HUE029250T2 (pl)
LT (1)	LT2544705T (pl)
PL (1)	PL2544705T3 (pl)
PT (1)	PT2544705T (pl)
RS (1)	RS55154B1 (pl)
SI (1)	SI2544705T1 (pl)
SM (1)	SMT201600334B (pl)
WO (1)	WO2011110861A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2020168033A2 (en) *	2019-02-13	2020-08-20	University Of Florida Research Foundation, Inc.	Targeting lung-resident tnfr2+ cdc2 (r2d2) subpopulation to treat asthma
WO2022018422A1 (en)	2020-07-20	2022-01-27	Synairgen Research Limited	Inhaled interferon-beta for improving outcome in sars-cov-2 infected patients
GB202014114D0 (en)	2020-09-08	2020-10-21	Synairgen Res Ltd	Use of inhaled interferon-beta to treat virus-induced exacerbations in copd patients undergoing treatment with a systemic corticosteroid
WO2022154542A1 (ko) *	2021-01-13	2022-07-21	에이비온 주식회사	잠재적인 호흡기바이러스 감염 개체에 인터페론-베타를 투여하는 것을 포함하는 호흡기바이러스에 대한 예방적 투여 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6030609A (en)	1995-05-19	2000-02-29	Case Western Reserve University	Method and composition for treating paramyxovirus
PE20010540A1 (es) *	1999-07-30	2001-05-15	Procter & Gamble	Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
GB2362884A (en)	2000-05-30	2001-12-05	Isis Innovation	Extended duration of airway gene therapy
AU2004270102B2 (en) *	2003-05-23	2009-10-01	Pestka Biomedical Laboratories, Inc.	Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections
US7482149B2 (en)	2003-06-09	2009-01-27	Genome Institute Of Singapore	Inhibition of SARS coronavirus infection with clinically approved antiviral drugs
CN1910195A (zh) *	2003-08-28	2007-02-07	辉阳科技美国公司	通过空间构象调节蛋白质功能
GB0518425D0 (en) *	2005-09-09	2005-10-19	Imp College Innovations Ltd	Methods
GB0405634D0 (en) *	2004-03-12	2004-04-21	Univ Southampton	Anti-virus therapy for respiratory diseases
CN1927389B (zh) *	2004-09-10	2012-11-14	北京金迪克生物技术研究所	含有人干扰素的药物组合物在制备预防或/和治疗呼吸道病毒感染疾病药物方面的应用
CN1927388B (zh) *	2004-09-10	2011-02-02	北京金迪克生物技术研究所	含有人干扰素的药物组合物
AU2006210753B2 (en) *	2005-02-04	2011-06-23	Swedish Orphan Biovitrum International Ab	Method and use of interferon compositions for the treatment of avian influenza
EP1922081B1 (en)	2005-09-09	2012-08-15	Imperial Innovations Limited	Interferon lambda therapy for treatment of respiratory diseases
EP1951285A2 (en) *	2005-11-18	2008-08-06	Ares Trading S.A.	Interferon in influenza
GB0609410D0 (en)	2006-05-12	2006-06-21	Viragen Inc	Method for the production of a type 1 interfemon in a transgenic avian
WO2008143892A1 (en)	2007-05-18	2008-11-27	New York University	Method of treating tuberculosis with interferons
CA2589613A1 (en)	2007-05-18	2008-11-18	Synairgen Plc	Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly

2011
- 2011-03-10 HU HUE11730046A patent/HUE029250T2/en unknown
- 2011-03-10 HR HRP20161158TT patent/HRP20161158T1/hr unknown
- 2011-03-10 DK DK11730046.7T patent/DK2544705T3/en active
- 2011-03-10 CA CA2792727A patent/CA2792727C/en active Active
- 2011-03-10 SI SI201130956A patent/SI2544705T1/sl unknown
- 2011-03-10 RS RS20160753A patent/RS55154B1/sr unknown
- 2011-03-10 WO PCT/GB2011/050480 patent/WO2011110861A2/en not_active Ceased
- 2011-03-10 ES ES11730046.7T patent/ES2592528T3/es active Active
- 2011-03-10 CN CN2011800135925A patent/CN102883741A/zh active Pending
- 2011-03-10 PL PL11730046T patent/PL2544705T3/pl unknown
- 2011-03-10 CN CN201710145580.7A patent/CN107050431A/zh active Pending
- 2011-03-10 EP EP11730046.7A patent/EP2544705B1/en active Active
- 2011-03-10 PT PT117300467T patent/PT2544705T/pt unknown
- 2011-03-10 LT LTEP11730046.7T patent/LT2544705T/lt unknown
- 2011-03-10 JP JP2012557607A patent/JP5926200B2/ja active Active
- 2011-03-10 US US13/583,976 patent/US9421243B2/en active Active
2016
- 2016-09-12 CY CY20161100897T patent/CY1117985T1/el unknown
- 2016-09-21 SM SM201600334T patent/SMT201600334B/it unknown

Also Published As

Publication number	Publication date
CA2792727A1 (en)	2011-09-15
SI2544705T1 (sl)	2016-11-30
US20130064792A1 (en)	2013-03-14
CN107050431A (zh)	2017-08-18
RS55154B1 (sr)	2017-01-31
DK2544705T3 (en)	2016-09-19
US9421243B2 (en)	2016-08-23
EP2544705A2 (en)	2013-01-16
LT2544705T (lt)	2016-10-10
CA2792727C (en)	2019-06-04
WO2011110861A3 (en)	2011-11-24
HUE029250T2 (en)	2017-04-28
HRP20161158T1 (hr)	2016-11-18
JP5926200B2 (ja)	2016-05-25
CY1117985T1 (el)	2017-05-17
EP2544705B1 (en)	2016-08-31
ES2592528T3 (es)	2016-11-30
WO2011110861A2 (en)	2011-09-15
PT2544705T (pt)	2016-09-21
JP2013522282A (ja)	2013-06-13
CN102883741A (zh)	2013-01-16
SMT201600334B (it)	2016-11-10

Publication	Publication Date	Title
PL2521562T3 (pl)	2020-04-30	Ev576 do zastosowania w leczeniu zakażeń wirusowych dróg oddechowych
ZA201205829B (en)	2013-05-29	Treatment of respiratory disorders
EP2621588A4 (en)	2014-09-03	METHODS AND COMPOSITIONS FOR TREATING DISEASE USING INHALATION
AU336564S (en)	2011-05-17	Respiratory mask
ZA201303475B (en)	2014-04-30	Butterfly nasal mask
IL221874A (en)	2016-09-29	History of pyrimidine and their use in the treatment of respiratory diseases such as copd
ZA201207591B (en)	2015-06-24	Improvements relating to respiratory apparatus
IL225668A0 (en)	2013-06-27	The compositions for the treatment of disorders in the upper respiratory tract
IL222890A0 (en)	2012-12-31	Medicaments for the treatment of il-1beta related conditions
IL218391A0 (en)	2012-04-30	Combination vaccines against respiratory tract diseases
AU339359S (en)	2011-11-10	Respiratory mask and/or components thereof
EP2638389A4 (en)	2016-12-21	TREATMENT OF EXTRACTION OF RENEWAL
GB201002243D0 (en)	2010-03-31	Respiratory disease treatment
IL227666A0 (en)	2013-09-30	Aclidinium for use in improving the quality of sleep in respiratory patients
GB201002224D0 (en)	2010-03-31	Respiratory disease treatment
LT2544705T (lt)	2016-10-10	Interferono beta panaudojimas gripo sukeltų apatinių kvėpavimo takų ligų gydymui
GB201006353D0 (en)	2010-06-02	Nasal inhaler
GB2490473B (en)	2017-06-14	Process for the preparation of hydrocolloid particulates and use thereof
GB201002235D0 (en)	2010-03-31	Respiratory disease treatment
GB201001903D0 (en)	2010-03-24	Respiratory disease treatment
GB201001893D0 (en)	2010-03-24	Respiratory disease treatment
GB201002841D0 (en)	2010-04-07	Treatment of inflammatory respiratory disease
GB201001912D0 (en)	2010-03-24	Treatment of respiratory disorders
GB201101770D0 (en)	2011-03-16	Treatment of inflammatory respiratory disease
AU336831S (en)	2011-05-27	Respiration mask